Experimental validation and identification of ferroptosis-associated biomarkers for diagnostic and therapeutic targeting in hearing loss
Ferroptosis is a potential pathological mechanism in hearing loss research, and the nine ferroptosis-related genes identified provide promising targets for exploring new diagnostics and treatments for hearing loss. Notably, <i>MEF2C</i> and <i>NEDD4</i> are associated with ARHL.
Authors
- Tianyu Ma (ORCID: https://orcid.org/0000-0002-1405-2042)
- Mengting Liu (ORCID: https://orcid.org/0000-0003-1736-1681)
- Tianhong Zhang (ORCID: https://orcid.org/0000-0002-5379-7119)
- Li Jiang (ORCID: https://orcid.org/0009-0004-4649-9270)
- Chenyang Yuan
- Gongrui Tang
- Qi Hu (ORCID: https://orcid.org/0009-0000-7199-8566)
Institutions
- Harbin Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Aging Neuroscience
- Published
- 2025-04-25
- DOI
- https://doi.org/10.3389/fnagi.2025.1526519
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Harbin Medical University
- Key Research and Development Program of Heilongjiang
- Natural Science Foundation of Heilongjiang Province
- National Key Research and Development Program of China